BIO-Key International Inc

BIO-Key International Inc(BKYI)股票分析

$2.740

+0.835 (+30.48%)收盘时

Loading chart…
最高
3.250
开盘
2.710
成交量加权均价
2.85
成交量
32.44M
市值
2.81M
最低
2.560
成交额
92.45M
企业价值/息税折旧摊销前利润(TTM)
-1.15

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.

AI 分析 of BIO-Key International Inc (BKYI)

买入

BIO-Key International Inc is a good buy right now due to its recent 57.49% price increase over the last 5 days and a gross margin of 87.19% in Q2 2026, indicating strong profitability potential. The current price of $2.63 is well below its Fibonacci resistance levels, suggesting room for growth. However, the main risk is the negative earnings per share of -0.56 reported in Q2 2026, which reflects ongoing financial challenges.

分析师评级(1)

买入
1 买入
0 持有
0 卖出
当前: 2.74
最低
—
平均
—
最高
—

估值指标

BIO-Key International Inc(BKYI)当前预期市盈率为 0.00,5 年平均预期市盈率为 -4.52。

预期市盈率

合理
5 年均值 P/E
-4.52
当前P/E
0.00
高估
1.94
低估
-10.98

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
-0.24
当前EV/EBITDA
-1.15
高估
0.60
低估
-1.09

预期市销率

合理
5 年均值 P/S
0.78
当前P/S
0.39
高估
1.35
低估
0.21

Alphio AI 对 BKYI 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%BKYI

$0.91

情景价格

基

基准

基准 · 50%BKYI

$0.79

情景价格

悲

悲观

悲观 · 25%BKYI

$0.72

情景价格

事件时间线

2026-10-22 (ET)

05:30:00

BIO-key Selected by Middle East Government for Security Project

2026-10-13 (ET)

05:30:00

BIO-key Secures New Customer in Middle East Government Security Agency

2026-10-09 (ET)

17:30:00

Selling Stockholders Plan to Sell 1.24M Shares of Common Stock

2026-09-29 (ET)

06:30:00

BIO-key Partners with Al Majlis Group for Strategic Collaboration

2026-08-10 (ET)

05:30:00

BIO-key and Visualforma Awarded New Contract by Portuguese National Security Agency

资讯

BKYI 常见问题 —— 由 Alphio AI 解答

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

BIO-Key International Inc is a good buy right now due to its recent 57.49% price increase over the last 5 days and a gross margin of 87.19% in Q2 2026, indicating strong profitability potential. The current price of $2.63 is well below its Fibonacci resistance levels, suggesting room for growth. However, the main risk is the negative earnings per share of -0.56 reported in Q2 2026, which reflects ongoing financial challenges.

1 analysts cover BKYI: 1 rate it Buy, 0 Hold and 0 Sell.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易